[HTML] nature.com

[HTML][HTML] Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

A Hoshina, T Kawamoto, SI Sueta, SI Mae, T Araoka… - Scientific reports, 2018 - nature.com
Cell therapy using renal progenitors differentiated from human embryonic stem cells
(hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce …
被引用次数：29 相关文章

Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

保科 - Scientific Reports, 2018 - cir.nii.ac.jp
抄録 Cell therapy using renal progenitors differentiated from human embryonic stem cells
(hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce …

Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

A Hoshina, T Kawamoto, SI Sueta, SI Mae… - Scientific …, 2018 - pubmed.ncbi.nlm.nih.gov
Cell therapy using renal progenitors differentiated from human embryonic stem cells
(hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce …

Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

A Hoshina, T Kawamoto, SI Sueta, SI Mae… - Scientific …, 2018 - ui.adsabs.harvard.edu
Cell therapy using renal progenitors differentiated from human embryonic stem cells
(hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce …

[引用][C] Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

A Hoshina - 2018 - ci.nii.ac.jp
CiNii 博士論文 - Development of new method to enrich human iPSC-derived renal progenitors
using cell surface markers CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …

Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

A Hoshina, T Kawamoto, SI Sueta, SI Mae… - Scientific …, 2018 - keio.elsevierpure.com
抄録 Cell therapy using renal progenitors differentiated from human embryonic stem cells
(hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce …
[PDF] kyoto-u.ac.jp

[PDF][PDF] Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

A Hoshina - 2018 - repository.kulib.kyoto-u.ac.jp
Cell therapy using renal progenitors differentiated from human embryonic stem cells
(hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce …
[PDF] core.ac.uk

[PDF][PDF] Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

A Hoshina, T Kawamoto, SI Sueta, SI Mae, T Araoka… - Scientific Reports, 2018 - core.ac.uk
Cell therapy using renal progenitors differentiated from human embryonic stem cells
(hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce …

Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers.

A Hoshina, T Kawamoto, SI Sueta, SI Mae… - Scientific …, 2018 - europepmc.org
Cell therapy using renal progenitors differentiated from human embryonic stem cells
(hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce …
[HTML] nih.gov

[HTML][HTML] Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers

A Hoshina, T Kawamoto, SI Sueta, SI Mae… - Scientific …, 2018 - ncbi.nlm.nih.gov
Cell therapy using renal progenitors differentiated from human embryonic stem cells
(hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce …